Sun Pharmaceutical Industries is addressing regulatory issues at three facilities, including an import alert at Halol.

Sun Pharma is stepping up regulatory compliance efforts at three USFDA-flagged facilities, including Halol, Mohali, and Dadra.

Sun Pharma aims to enhance compliance and R&D investment for global speciality products, targeting mid to high single-digit ...

BRITS have been warned eyedrops used as a hayfever remedy have been recalled over risk of serious infection. Retailers have ...

Mumbai: Sun Pharma Advanced Research Company Limited (SPARC) has announced the incorporation of its wholly owned subsidiary, ...

Sun Pharma is working to resolve USFDA compliance issues at three facilities: Halol, Mohali, and Dadra. The company is implementing CAPA and anticipates mid to high single-digit growth in FY26.

NEW DELHI: Drug makers Glenmark, Sun Pharma and Zydus are recalling products in the US for manufacturing issues, the US Food and Drug Administration (USFDA) said in its latest Enforcement Report.

As President Donald Trump enters the second full week of his trade war, he is signaling a new phase of tariffs targeting tech products and pharmaceuticals. Despite criticism from economists who ...

Sun Pharma appoints Richard Ascroft as North America CEO to lead U.S. and Canada operations, including new drug launches and ...

Sun Pharma's high-growth global specialty portfolio spans innovative products in dermatology, ophthalmology, and onco-dermatology and accounts for over 18% of company sales.

Sun Pharmaceutical Industries Ltd, India’s largest drugmaker, has long been a favourite among investors. However, recent challenges, including a market-wide sell-off and a setback in its ...

N ew Delhi: Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues, according to the US Food and Drug Administration (USFDA). The New Jersey-based ...